Tanaka Rina, Matsuzaka Masashi, Nakaji Shigeyuki, Sasaki Yoshihiro
Department of Medical Informatics, Hirosaki University Graduate School of Medicine, Japan
Department of Social Medicine, Hirosaki University Graduate School of Medicine, Japan. Email: r-tana@ hirosaki-u.ac.jp
Asian Pac J Cancer Prev. 2016 Nov 1;17(11):5025-5030. doi: 10.22034/APJCP.2016.17.11.5025.
The objective of this study was to clarify how distance from place of residence to the nearest specialist cancer hospital affects the survival of lung cancer patients and the treatment received. For all patients diagnosed with lung cancer in the Aomori cancer registry database for the period from 2009 to 2011 (n=3,986). The distance to the treating hospital was measured as the straight line from a person’s place of residence, and compared with findings from the Ederer II method for calculating relative survival. Information on treatments given was obtained by data extraction. We defined a hospital having respiratory medicine as specialist, while all private hospitals and clinics were included in the general category. Patients attending specialist hospitals numbered 2,548 (67.0%), and those treated at general institutions were 1,255 (33.0%). The patients who had the lowest relative survival with localized lesions lived <20 km from general hospitals and clinics. With more advanced stages, relative survival of those living <20 km from a specialist hospital was the lowest. Although the survival rate was not affected by the distance between place of residence and hospital, even when patients are diagnosed at a localized stage at a general hospital or clinic
本研究的目的是阐明居住地与最近的专科癌症医院之间的距离如何影响肺癌患者的生存情况及所接受的治疗。研究对象为2009年至2011年青森癌症登记数据库中所有被诊断为肺癌的患者(n = 3986)。到治疗医院的距离是从个人居住地起测量的直线距离,并与Ederer II法计算相对生存情况的结果进行比较。通过数据提取获取有关所接受治疗的信息。我们将设有呼吸内科的医院定义为专科医院,而所有私立医院和诊所都归为综合类别。前往专科医院就诊的患者有2548名(67.0%),在综合机构接受治疗的患者有1255名(33.0%)。局限性病变患者中相对生存情况最差的是那些居住在距离综合医院和诊所不到20公里的患者。对于更晚期的患者,居住在距离专科医院不到20公里的患者相对生存情况最差。尽管生存率不受居住地与医院之间距离的影响,即便患者是在综合医院或诊所被诊断为局限性阶段时